Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise?

Eur Respir J. 2007 Feb;29(2):229-30. doi: 10.1183/09031936.00159606.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cystic Fibrosis / drug therapy*
  • Humans
  • Lung Diseases / drug therapy*
  • Serine Proteinase Inhibitors / therapeutic use*
  • Treatment Outcome
  • alpha 1-Antitrypsin / therapeutic use*

Substances

  • Serine Proteinase Inhibitors
  • alpha 1-Antitrypsin